Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 161-165 , July 2007

Residual high-grade angina after enhanced external counterpulsation therapy

  • Peter A. McCullough

      Affiliations

    • Department of Medicine, Divisions of Cardiology, Nutrition and Preventive Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA
    • Corresponding Author InformationCorresponding author. Divisions of Cardiology, Nutrition, and Preventive Medicine, William Beaumont Hospital, 4949, Colidge Highway, Royla Oak, MI 48073, USA. Tel.: +1 248 655 5948; fax: +1 248 655 5901.
    • ,
  • Timothy D. Henry

      Affiliations

    • Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital, Minneapolis, MN, USA
    • ,
  • Elizabeth D. Kennard

      Affiliations

    • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA
    • ,
  • Sheryl F. Kelsey

      Affiliations

    • Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA, USA
    • ,
  • Andrew D. Michaels

      Affiliations

    • Division of Cardiology, Department of Medicine, University of Utah, Salt Lake City, UT, USA
    • ,
  • for the IEPR Investigators

Received 6 December 2006 ,Accepted 12 December 2006.

References 

  1. Shea ML, Conti CR, Arora RR. An update on enhanced external counterpulsation. Clin Cardiol. 2005;28(3):115–118
  2. Soran O. A new treatment modality in heart failure enhanced external counterpulsation (EECP). Cardiol Rev. 2004;12(1):15–20
  3. Arora RR, Chou TM, Jain D, Crawford L, McKiernan T, Nesto RW. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833–1840
  4. Michaels AD, Kennard ED, Kelsey S, et al. Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation (EECP)?: data from the International Enhanced External Counterpulsation Patient Registry. Clin Cardiol. 2001;24:453–458
  5. Barsness G, Feldman A, Holmes D, et al. The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results. Clin Cardiol. 2001;24:435–442
  6. Spertus JA, Jones P, McDonell M, Fan V, Fihn SD. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 2002;106(1):43–49
  7. McCullough PA. Chronic angina: new medical options for treatment. Rev Cardiovasc Med. 2005;6(3):152–161
  8. Abrams J. Clinical practice. Chronic stable angina. N Engl J Med. 2005;352(24):2524–2533
  9. Al-Mallah MH, Tleyjeh IM, Abdel-Latif AA, Weaver WD. Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. J Am Coll Cardiol. 2006;47(8):1576–1583
  10. Wu G, Du Z, Hu C, Zheng Z, Zhan C, Ma H, et al. Angiogenic effects of long-term enhanced external counterpulsation in a dog model of myocardial infarction. Am J Physiol Heart Circ Physiol. 2006;290(1):H248–H254[electronic publication 2005 Aug 19]
  11. Loh PH, Louis AA, Windram J, Rigby AS, Cook J, Hurren S, et al. The immediate and long-term outcome of enhanced external counterpulsation in treatment of chronic stable refractory angina. J Intern Med. 2006;259(3):276–284

☆ The IEPR is sponsored by Vasomedical, Inc., Westbury, NY.

PII: S1553-8389(06)00273-9

doi: 10.1016/j.carrev.2006.12.003

Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 161-165 , July 2007

Article Tools

* Image Usage & Resolution